Gene ID | Gene Name | Gene Symbol ▲ | Disease Ontology |
---|---|---|---|
115138492 | protein-O-mannosyltransferase 2 |
|
|
115144263 | RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
|
115108969 | ribitol xylosyltransferase 1 |
|
|
115147036 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 |
|
|
115141165 | beta-1,4-galactosyltransferase 3 |
|
|
115129272 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
|
115106811 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
|
115125434 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 2a |
|
|
115112982 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase |
|
|
115104302 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
|
|
115119707 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
|
|
115119666 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
|
|
115114980 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
|
|
115118029 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
|
|
115120182 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
|
|
115118012 | transmembrane O-mannosyltransferase targeting cadherins 1 |
|
|
115133960 | transmembrane O-mannosyltransferase targeting cadherins 3 |
|
|
115130657 | transmembrane O-mannosyltransferase targeting cadherins 4 |
|
|
115120930 | UDP-glucose ceramide glucosyltransferase |
|
|
115129796 | UDP-glucose glycoprotein glucosyltransferase 1 |
|
|
115109632 | UDP-glucose glycoprotein glucosyltransferase 2 |
|
|
115108038 | uronyl 2-sulfotransferase a |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024